A Free Radical Scavenger (Lazaroid U75412E) Attenuates Tumor Necrosis Factor-Alpha Generation in a Rabbit Model of Smoke-Induced Lung Injury

Respiration

Volumn 64, Issue 5, 1997, Pages 358-363

  Wang, Shengjun ^a,b   Lantz, R Clark ^b,c   Rider, Evelyn D ^a,b   Chen, Guan Jie ^c   Breceda, Veronica ^a   Hays, Allison M ^a   Robledo, Raymond F ^a,d   Tollinger, Brian J ^a   Dinesh, S V R ^a,d   Witten, Mark L ^a,b,d  

^a Joan B And Donald R Diamond Lung Injury Laboratories of the Steele Memorial Children s Research Center   (United States)

^b Respiration Sciences Center   (United States)

^c Department of Cell Biology and Anatomy ^*  (Germany)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Acute lung injury; Lazaroid; Pulmonary alveolar macrophages; Smoke; Superoxide; Tumor necrosis factor and

Indexed keywords

LAZAROID; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; INHALATION; INHALATIONAL DRUG ADMINISTRATION; LUNG ALVEOLUS HYPOVENTILATION; LUNG ALVEOLUS MACROPHAGE; LUNG EDEMA; LUNG INJURY; LUNG WEIGHT; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOKE; TIME;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL ASSAY; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MACROPHAGES, ALVEOLAR; NECROSIS; PULMONARY GAS EXCHANGE; RABBITS; SMOKE INHALATION INJURY; STEROIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030811224     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000196704     Document Type: Article

References (32)

1. Thompson P, Herndon DN, Abston S, Rutan T: Effect of early excision on patients with major thermal injury, J Trauma 1987;27:205-207.
2. Johnson D, Hurst T, Prasad K, Wilson T, Sax-ena A, Murphy F, Mayers I: Lazaroid pretreatment preserves gas exchange in endotoxin-treated dogs, J Crit Care 1994;9:213-222.
3. Antonini JM, van Dyke K, DiMatteo M, Rea-sor MJ: Attenuation of acutc inflammatory effects of silica in rat lung by 21-aminosteroid, U74389G, Inflammation 1995:19:9-21.
4. Aeba R, Killinger WA, Keenan RJ, Youscm SA, Hamamoto I, Hardesty RL, Griffith BP: Lazaroid U74500A as an additive to University of Wisconsin solution for pulmonary grafts in the rat transplant model, J Thorac Cardio-vascSurg 1992:104:1333-1339.
5. Shenkar R, Abraham E: Effects of treatment with the 21-aminosteroid, U74389F, on pulmonary cytokine expression following hemorrhage and resuscitation, Crit Care Med 1995: 23:132-139.
6. Griffin RL, Krzesicki RF, Fidler SF, Rosen-bloom CL, Auchampach JA, Manning AM, Haas JV, Cammarata SK, Chin JE, Richards IM: Attenuation of oxidant-induced lung injury by 21-aminostcroids (lazaroids): Correlation with the mRNA expression for E-selectin, P-selectin, ICAM-I, and VCAM-1, Environ Health Perspect 1994;102(suppl 10): 193-200.
7. McLaughlin GE, Frank L: Effects of the 21-aminosteroid, U74389F, on bleomycin-in-duced pulmonary fibrosis in rats, Crit Care Med 1994:22:313-319.
8. Braughler JM, Pregenzcr JF, Chase RL, Duncan LA, Jacobscn EL, McCall JM: Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation, J Biol Chem 1987;262:10438-10440.
9. Braughler JM, Chase RL, Neff GL, Yonkers PA, Day JS, Hall ED, Scthy VH, Lahti RA: A new 21-aminosteroid antioxidation lacking glucocorticoid activity stimulates adrenocorti-colropin secretion and blocks arachidonic acid release from mouse pituitary tumor (AtT-20) cells, J Pharmacol Exp Ther 1988:244:423-427.
10. Audus KL, Guillot FL, Braughler JM: Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells, Free Radic Biol Med 1991,11: 361-371.
11. Thomas PD, Mao GD, Rabinovitch A, Poz-nansky MJ: Inhibition of superoxide-generat-ing NADPH oxidase of human neutrophils by lazaroids (2I-aminosteroids and 2-methylami-nochromans), Biochem Pharmacol 1993;45: 241-251.
12. Witten ML, Lantz RC, Grad R, Scidner S, Hubbard AK, Quan SF, Lenten RJ: Effect of smoke inhalation on immediate changcs in lung chemical mediators, RcsCommun Chem Pathol Pharmacol 1991;74:259-272.
13. Ozawa T, Hayakawa M, Takamura T, Sugiya-ma S, Suzuki K, Iwata M, Taki F, Tamita T: Biosynthesis of leukotoxin 9,10-epoxy-12-oc-tadcccnoate, by leukocytes in lung lavages of rat after exposure to hyperoxia, Biochem Bio-phys ResCommun 1986;134:1071-1078.
14. Bidani A, Wang CZ, Heming TA: Early effects of smoke inhalation on alveolar macrophage functions, Bums 1996;22:101-106.
15. Brieland JK, Kunkel RG, Fantonc JC: Pulmonary alveolar macrophages function during acute inflammatory lung injury, Am Rev Res-pirDis 1987; 135:1300-1306.
16. Brieland JK, Flory CM, Jones ML, Miller GR, Remick DG, Warren JS, Fantone JC: Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-a, and interleukin-15, Am J Respir Cell Mol Biol 1995; 12:104-109.
17. Kelley J: Cytokines of the lung (review), Am Rev Respir bis 1990:141:765-788.
18. Li XY, Donaldson K, Brown D, MacNee W: The role of tumor nccrosis factor in increased airspace epithelial permeability in acutc lung inflammation, Am J Respir Cell Mol Biol 1995:13:185-195.
19. Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J: Cytokine expression by neutrophils and macrophages in vivo: Endotoxin induces tumor nccrosis factor-a, macrophage inflammatory protein-2, interleukin-li, and interleukin-6 but not RANTES or transforming growth factor-a I mRNA expression in acute lung inflammation, Am J Respir Cell Mol Biol 1994;10:148-153.
20. Myrvik QN, Leake ES, Fariss B: Studies on pulmonary alveolar macrophages from the normal rabbit: A technique to produce them in a high state of purity,.I Immunol 1961:86:128-132.
21. Eskandari MK, Nguyen DT, Kunkel SL, Remick DG:WEHI 164 subclone 13 assay for TNF: Sensitivity, specificity, and reliability, Immunol Invest 1990:19:69-79.
22. Espevik T, Nissen-Mcyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor nccrosis factor from human monocytes, J Immunol Methods 1986:95: 99-105.
23. DiGregorio KA, Cilento EV, Lantz RC: Measurement of superoxidc release from single pulmonary alveolar macrophages, Am J Phvsiol 1987;252:C677-C683.
24. Pinkerton KE, Crapo J D: Morphomctery of the alveolar region of the lung; in Witschi HP, Brain JD (eds): Toxicology of inhaled materials, Berlin, Springer, 1985, pp 259-285.
25. Braughler JM, Chase RL, Pregenzer JF: Oxidation of ferrous iron during peroxidation of lipid substrates, Biochim Biophys Acta 1987:921: 457-464.
26. Hays AM, Lantz RC, Vcrmeulen M, Chen G, Witten ML: U75412E pre-treatment before acutc smoke exposure causes a large increase in lung prostacyclin concentrations, FASEB J 1993;7:A507.
27. Rider ED, Witten ML, Lantz RC, Hays AM, Dizon-Co L: A free radical scavenger (lazaroid U754I2E) prevents smoke inhalation-induced changes in alveolar surfactant phospholipids, Am Rev Respir Dis 1993; 147:A363.
28. 99mTcDTPA lung clearance, Exp Lung Res 1990:16:339-353.
29. Oulton MR, Janigan DT, MacDonald JMR, Faulker GT, Scott JE: Effects of smoke inhalation on alveolar surfactant subtypes in mice, Am J Pathol 1994;145:941-950.
30. Krzanowski JJ: Oxidant-induced alterations of lung surfactant system, J Ha Med Assoc 1994; 81:49-51.
31. Linares HA, Herndon DN, Traber DL: Sequence of morphologic events in experimental smoke inhalation, J Burn Care Rehabil 1989; 10:27-37.
32. Wang S, Lantz RC, Chen GJ, Breceda V, Rider E, Hays AM, Parliman G, Tollinger BJ, Robledo RF, Kunke K, Tinajero J, Witten ML: The prophylactic effects of U75412E pretreatment in a smoke-induced lung injury rabbit model, Pharmacol Toxicol 1996:79:231-237.